The Commission shall take all necessary measures to prevent any malfunction and to identify it, without undue delay, when it occurs.
Where an actor or an authorised user suspects a malfunction, it shall immediately inform the Commission thereof.
Where the Commission identifies a malfunction, it shall take the following measures:
display, without delay, a notice to that regard (‘malfunction notice’) on the restricted website or the public website, as applicable, unless the nature of the malfunction prevents the Commission from doing so, in which case it shall, to the extent possible, display the notice on the Commission’s dedicated website for medical devices;
suspend the periods for submission of data in Eudamed set out in Regulations (EU) 2017/745 and (EU) No 2017/746, where the malfunction hinders entering of the relevant data.
Where the Commission suspends the periods for submission of data to Eudamed as provided for in the first subparagraph, point (b), the malfunction notice shall specify the time of the display of that notice and the likely duration of the suspension.
In addition to the suspension of periods referred to in paragraph 3, first subparagraph, point (b), of this Article, where a malfunction hinders compliance with any of the obligations referred to in Article 80, Article 87(1), Article 89(5), (7), (8) and (9), Article 95(2), (4) and (6), or Article 98(2) of Regulation (EU) 2017/745, or in Article 76, Article 82(1), Article 84(5), (7), (8) and (9), Article 90(2), (4) and (6) or Article 93(2) of Regulation (EU) 2017/746, either of the following procedure shall apply:
where the malfunction lasts more than 12 hours following the display of the malfunction notice, the actor shall without delay provide general information about the relevant data and an indication that the submission of data is pending due to the malfunction to the Commission, to the national competent authorities concerned and to the notified body that issued the certificate of conformity referred to in Article 56 of Regulation (EU) 2017/745 or Article 51 of Regulation (EU) 2017/746, as applicable;
where the malfunction lasts more than 24 hours following the display of the malfunction notice, or where the malfunction lasts less than 24 hours and it is requested by the national competent authorities concerned after receiving the information referred to in point (a) of this paragraph, the actor shall without delay provide the relevant data to those authorities, in the manner prescribed by them.
In addition to the suspension of periods referred to in paragraph 3, first subparagraph, point (b) of this Article, in the event of a malfunction that hinders compliance with one of the obligations set out in Regulation (EU) 2017/745 or Regulation (EU) 2017/746 other than the obligations referred to in paragraph 4 of this Article, the following procedure shall apply:
where the malfunction lasts more than 36 hours following the display of the malfunction notice, the actor shall without delay provide general information about those data and an indication that the submission of data is pending due to the malfunction to the Commission, to the national competent authorities concerned and to the notified body that issued the certificate of conformity referred to in Article 56 of Regulation (EU) 2017/745 or Article 51 of Regulation (EU) 2017/746, as applicable;
where the malfunction lasts more than five days following the display of the malfunction notice, the actor shall inform the national competent authorities concerned thereof and shall, if they so request, provide them with the relevant data, in the manner prescribed by them.
When the Commission has established that the malfunction has ceased, it shall communicate that information to the competent authorities. In addition, the Commission shall display a notice to that regard on the restricted website and/or the public website, as applicable. Both the communication and the notice shall indicate the duration of the malfunction and of the suspension of periods referred to in paragraph 3, point (b).
When the Commission has displayed the notice referred to in paragraph (6), actors shall without delay enter the data that they were hindered to submit during the malfunction in Eudamed.